RARE John Richard Pinion sells $608K worth of shares
Mar 05, 2025, 5:35 AM
0.00%
What does RARE do
Ultragenyx Pharmaceutical, based in Novato, California, focuses on developing therapies for rare genetic diseases and has four approved products, including Crysvita and Mepsevii. The company went public on January 31, 2014, and employs 1,276 people.
John Richard Pinion sold 14,439 shares of RARE on 3 March at $42.10 per share, worth a total of $608K. They now own 107,766 RARE shares, or a 12% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
